Neurogene (NGNE) Short Interest Ratio & Short Volume → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free NGNE Stock Alerts $31.55 +0.91 (+2.97%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Neurogene Short Interest DataCurrent Short Volume1,020,000 sharesPrevious Short Volume988,100 sharesChange Vs. Previous Month+3.23%Dollar Volume Sold Short$35.17 millionShort Interest Ratio / Days to Cover7.7Last Record DateApril 30, 2024Outstanding Shares12,870,000 sharesFloat Size11,520,000 sharesShort Percent of Float8.85%Today's Trading Volume82,957 sharesAverage Trading Volume118,695 sharesToday's Volume Vs. Average70% Short Selling Neurogene ? Sign up to receive the latest short interest report for Neurogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNGNE Short Interest Over TimeNGNE Days to Cover Over TimeNGNE Percentage of Float Shorted Over Time Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Neurogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,020,000 shares $35.17 million +3.2%8.9%7.7 $34.48 4/15/2024988,100 shares $36.98 million +9.1%8.6%7.1 $37.43 3/31/2024906,000 shares $46.12 million +130.4%7.9%6.7 $50.90 3/15/2024393,200 shares $14.76 million +50.8%3.4%3.4 $37.53 2/29/2024260,700 shares $8.10 million +68.2%2.3%3.4 $31.07 2/15/2024155,000 shares $4.65 million +295.4%1.3%2.4 $30.00 1/31/202439,200 shares $1.18 million No Change0.4%0.8 $30.16 NGNE Short Interest - Frequently Asked Questions What is Neurogene's current short interest? Short interest is the volume of Neurogene shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,020,000 shares of NGNE short. 8.85% of Neurogene's shares are currently sold short. Learn More on Neurogene's current short interest. What is a good short interest ratio for Neurogene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGNE shares currently have a short interest ratio of 8.0. Learn More on Neurogene's short interest ratio. What is a good short interest percentage for Neurogene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.85% of Neurogene's floating shares are currently sold short. Is Neurogene's short interest increasing or decreasing? Neurogene saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,020,000 shares, an increase of 3.2% from the previous total of 988,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neurogene's float size? Neurogene currently has issued a total of 12,870,000 shares. Some of Neurogene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neurogene currently has a public float of 11,520,000 shares. How does Neurogene's short interest compare to its competitors? 8.85% of Neurogene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Neurogene: Adlai Nortye Ltd. (0.03%), Theravance Biopharma, Inc. (14.10%), Fulcrum Therapeutics, Inc. (4.83%), Korro Bio, Inc. (2.68%), PepGen Inc. (1.66%), Lexicon Pharmaceuticals, Inc. (9.52%), Travere Therapeutics, Inc. (16.83%), Entrada Therapeutics, Inc. (9.54%), Biomea Fusion, Inc. (50.32%), Annexon, Inc. (6.63%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Neurogene stock? Short selling NGNE is an investing strategy that aims to generate trading profit from Neurogene as its price is falling. NGNE shares are trading up $0.91 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neurogene? A short squeeze for Neurogene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NGNE, which in turn drives the price of the stock up even further. How often is Neurogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGNE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ANL Short Interest Data TBPH Short Interest Data FULC Short Interest Data KRRO Short Interest Data PEPG Short Interest Data LXRX Short Interest Data TVTX Short Interest Data TRDA Short Interest Data BMEA Short Interest Data ANNX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NGNE) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper